LOX and systemic sclerosis: In the current study, the lungs of bleomycin-treated mice had elevated levels of LOX and LOXL2 protein when compared to vehicle-treated animals 21 days after bleomycin dosage (Figure 3A), consistent with the elevated LOX and LOXL2 expression found in lungs of the SSc patients.